1. Academic Validation
  2. Neuropathic pain-alleviating activity of novel 5-HT6 receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamide

Neuropathic pain-alleviating activity of novel 5-HT6 receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamide

  • Bioorg Chem. 2021 Oct:115:105218. doi: 10.1016/j.bioorg.2021.105218.
Marcin Drop 1 Florian Jacquot 2 Vittorio Canale 3 Severine Chaumont-Dubel 4 Maria Walczak 3 Grzegorz Satała 5 Klaudia Nosalska 3 Gilbert Umuhire Mahoro 6 Karolina Słoczyńska 3 Kamil Piska 3 Sylvain Lamoine 2 Elżbieta Pękala 3 Nicolas Masurier 6 Andrzej J Bojarski 5 Maciej Pawłowski 3 Jean Martinez 6 Gilles Subra 6 Xavier Bantreil 6 Frédéric Lamaty 6 Alain Eschalier 2 Philippe Marin 4 Christine Courteix 2 Paweł Zajdel 7
Affiliations

Affiliations

  • 1 Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland; IBMM, Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
  • 2 Université Clermont Auvergne, INSERM U1107, NEURO-DOL, F-63000 Clermont-Ferrand, France.
  • 3 Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland.
  • 4 Institut de Génomique Fonctionelle, Université de Montpellier, CNRS INSERM, 34094 Montpellier, France.
  • 5 Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Str., 31-343 Kraków, Poland.
  • 6 IBMM, Université de Montpellier, CNRS, ENSCM, 34095 Montpellier, France.
  • 7 Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland. Electronic address: pawel.zajdel@uj.edu.pl.
Abstract

The diverse signaling pathways engaged by serotonin type 6 receptor (5-HT6R) together with its high constitutive activity suggests different types of pharmacological interventions for the treatment of CNS disorders. Non-physiological activation of mTOR kinase by constitutively active 5-HT6R under neuropathic pain conditions focused our attention on the possible repurposing of 5-HT6R inverse agonists as a strategy to treat painful symptoms associated with neuropathies of different etiologies. Herein, we report the identification of compound 33 derived from the library of 2-aryl-1H-pyrrole-3-carboxamides as a potential analgesic agent. Compound 33 behaves as a potent 5-HT6R inverse agonist at Gs, CDK5, and mTOR signaling. Preliminary ADME/Tox studies revealed preferential distribution of 33 to the CNS and placed it in the low-risk safety space. Finally, compound 33 dose-dependently reduced tactile allodynia in spinal nerve ligation (SNL)-induced neuropathic rats.

Keywords

5-HT(6) receptor inverse agonism; Cdk5 signaling; Flow chemistry; Neuropathic pain; Spinal nerve ligation; mTOR kinase.

Figures
Products